Education
About Us
Working with TipRanks
Follow Us
Tevogen Bio Holdings Inc. (TVGN)
:TVGN
TVGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.26 - $3.09
Previous CloseN/A
Volume2.03M
Average Volume (3M)964.63K
Market Cap
$185.41M
Enterprise Value$185.97M
Total Cash (Recent Filing)$1.97M
Total Debt (Recent Filing)$4.82M
Price to Earnings (P/E)―
Beta0.07
Next Earnings
Aug 14, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding185,693,440
10 Day Avg. Volume1,719,591
30 Day Avg. Volume964,625
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue468.92
Enterprise Value/Gross Profit1.89K
Enterprise Value/Ebitda-5.48
Forecast
1Y Price Target
$10.00Price Target Upside910.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Tevogen Bio Holdings News
TVGN FAQ
What was Tevogen Bio Holdings Inc.’s price range in the past 12 months?
Tevogen Bio Holdings Inc. lowest stock price was $0.26 and its highest was $3.09 in the past 12 months.
What is Tevogen Bio Holdings Inc.’s market cap?
Tevogen Bio Holdings Inc.’s market cap is $185.41M.
When is Tevogen Bio Holdings Inc.’s upcoming earnings report date?
Tevogen Bio Holdings Inc.’s upcoming earnings report date is Aug 14, 2025 which is in 6 days.
How were Tevogen Bio Holdings Inc.’s earnings last quarter?
Currently, no data Available
Is Tevogen Bio Holdings Inc. overvalued?
According to Wall Street analysts Tevogen Bio Holdings Inc.’s price is currently Undervalued.
Does Tevogen Bio Holdings Inc. pay dividends?
Tevogen Bio Holdings Inc. does not currently pay dividends.
What is Tevogen Bio Holdings Inc.’s EPS estimate?
Tevogen Bio Holdings Inc.’s EPS estimate is -0.05.
How many shares outstanding does Tevogen Bio Holdings Inc. have?
Tevogen Bio Holdings Inc. has 185,693,440 shares outstanding.
What happened to Tevogen Bio Holdings Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tevogen Bio Holdings Inc.?
Among the largest hedge funds holding Tevogen Bio Holdings Inc.’s share is Saba Capital Management. It holds Tevogen Bio Holdings Inc.’s shares valued at 0.
Tevogen Bio Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (910.10% Upside)
$10.00 (910.10% Upside)
Hedge Fund Trend
Decreased
By 5.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
117.90%
12-Months-Change
Fundamentals
Return on Equity
-124.74%
Trailing 12-Months
Asset Growth
21.10%
Trailing 12-Months
Company Description
Tevogen Bio Holdings Inc.
Tevogen Bio Holdings (TVGN) is a biotechnology company focused on the development and commercialization of innovative immunotherapies for the treatment of viral infections and cancers. The company's core products include advanced therapeutic solutions designed to harness the power of the immune system to target and eliminate disease-causing cells. Tevogen Bio operates within the biotech sector, leveraging cutting-edge research and development to deliver novel treatments that address unmet medical needs.
Technical Analysis
Codexis
―
Cidara Therapeutics
―
Corvus Pharmaceuticals
―
Nuvectis Pharma
―
CARGO Therapeutics, Inc.
―
Ownership Overview
77.55% Insiders
0.84% Mutual Funds
0.04% Other Institutional Investors
20.32% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---